Skip to main content
. 2023 Sep 26;8(2):416–428. doi: 10.1182/bloodadvances.2023010591

Figure 3.

Figure 3.

Outcomes in comparison with those of historical cohorts of children aged ≥2 but <4 years with high-risk ALL undergoing HSCT. (A) Probability of OS over time and (B) probability of EFS over time, showing the ALL-SCT BFM International trial of TBI/Eto (blue; n = 16), the ALL-SCT BFM 2003 trial of TBI/Eto (red; n = 35), and children aged >2 but ≤4 years in the FORUM study of chemotherapeutic conditioning (green; n = 101).